| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.83B | +2.1% | +10.0% |
| Cost of Revenue | $845.0M | -0.8% | +5.4% |
| R&D Expense | $126.0M | +7.7% | +12.5% |
| SG&A Expense | $465.0M | -2.3% | +2.4% |
| Operating Income | $399.0M | +13.0% | +33.0% |
| Interest Expense | $25.0M | +0.0% | -13.8% |
| Pre-tax Income | $408.0M |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.81B | +2.8% | +21.6% |
| Accounts Receivable | $1.50B | -1.5% | +9.7% |
| Inventory | $1.09B | +2.8% | +9.9% |
| Current Assets | $4.76B | +3.2% | +13.2% |
| Total Assets | $13.06B | +2.0% | +7.5% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $545.0M | +103.4% | — |
| Capital Expenditures | $169.0M | +81.7% | — |
| Investing Cash Flow | -$170.0M | -82.8% | — |
| Financing Cash Flow | -$366.0M | -64.9% | — |
| Free Cash Flow | $376.0M | +114.9% | — |
| +12.1% |
| +56.9% |
| Income Tax | $69.0M | +16.9% | +53.3% |
| Net Income | $339.0M | +11.1% | +57.7% |
| EPS (Basic) | $1.20 | +11.1% | +60.0% |
| EPS (Diluted) | $1.20 | +12.1% | +60.0% |
| $2.27B |
| +1.6% |
| +12.8% |
| Long-term Debt | $3.05B | +0.0% | -8.9% |
| Total Liabilities | $5.94B | +0.6% | -1.3% |
| Stockholders' Equity | $7.12B | +3.1% | +16.1% |